Tag: Heart / Stroke-Related: Stroke
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis
Bridging Therapy May Be Better for Large Vessel Occlusion Stroke
Better outcomes associated with IV thrombolysis followed by mechanical thrombectomy versus mechanical thrombectomy alone
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO
ASA: Endovascular Therapy Studied in Large Ischemic Stroke
Better functional outcomes but more intracranial hemorrhages seen with endovascular therapy plus medical care versus medical care alone
Time to Benefit Estimated for Intensive BP Control to Prevent Stroke
About 1.7 years of more intensive hypertensive treatment required to prevent one stroke per 200 adults aged 65 years or older
ASA: Scoring System May Predict Stroke Risk in COVID-19 Inpatients
Score based on six clinical factors including no fever at time of admission, no history of pulmonary disease, high white blood cell count
ASA: BP Telemonitoring Aids Stroke Survivors in Underserved Areas
Adherence to follow-up, blood pressure control better in those with remote BP monitoring, telehealth versus usual care
ASA: Less Bleeding Seen With Tenecteplase for Ischemic Stroke
Rate of symptomatic intracranial hemorrhage lower with tenecteplase than the current standard medication for thrombolysis, alteplase
ASA: Stroke Rates Down in Elderly, Up in Young Adults in the U.S.
Stroke incidence decreased among older adults nationwide and increased in 15- to 49-year-olds in the South and Midwest U.S.
